Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anshen Drop Pill for Insomnia (Heart-Liver Blood Deficiency)
CTR20192128Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Oct 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Anshen Dripping Pills in Insomnia, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Oct 2019; status: completed.
02
Drugs
Anshen Dripping Pills
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20192128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192128.